Clinical Trials Logo
  1. Home
  2. Embryo Transfer
  3. NCT02703181

Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers

Embryo Transfer Clinical Trial

Official title:
A Randomized, Placebo-controlled, Double-Blind (Sponsor Unblind), Repeat Dose, Ascending Cohort, Dose Escalation Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban and Its Major Metabolite in Healthy Women Volunteers Following Administration of Repeat Dosing of Epelsiban

Clinical Trial Summary

The current study is designed to assess the safety, tolerability and pharmacokinetics (PK) of additional repeat doses of epelsiban in healthy females, and will be the first dosing experience of repeat dosing at higher doses in women with this compound.

This study is a 14 day, randomized, placebo-controlled, double blind (sponsor unblind), repeat dose, ascending cohort, dose escalation study in healthy, female volunteers. Upon successful completion of the Screening period, a subject will be enrolled in the study. The study will be composed of three periods: Screening, Treatment and Follow-up. A subject's total time involved in the study will be approximately six weeks.

Cohorts will be conducted sequentially. Each subject will be enrolled in only one cohort. Ten subjects will be enrolled in each cohort and randomized to epelsiban (n=8) or placebo (n=2).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02703181
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 1
Start date July 9, 2015
Completion date September 10, 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03642665 - Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer Phase 4
Completed NCT01919502 - Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility Treatment N/A
Completed NCT03292770 - Mucus Removal Before Embryo Transfer N/A
Recruiting NCT06134609 - Does Sexual Intercourse Affect the Outcomes of Frozen-thawed Embryo Transfer? N/A
Completed NCT03040830 - Effect of Timing Progesterone Luteal Support on Embryo Transfer Phase 4
Recruiting NCT04725864 - Progesterone as Luteal Support in Frozen IVF Natural Cycles Phase 4
Recruiting NCT04619524 - Biomarkers of Endometrial Receptivity N/A
Completed NCT04297553 - Fresh Versus Freeze-only After CAPA IVM on PCOS Patients N/A
Completed NCT01846403 - Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility Setting N/A
Recruiting NCT02825290 - Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study Phase 4
Completed NCT01863680 - Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel Phase 3
Terminated NCT03386227 - Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT N/A
Recruiting NCT04124913 - Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles Phase 4
Completed NCT05364528 - Pregnancy Rate in Direct Versus Afterload Technique of Embryo Transfer
Completed NCT04253470 - Debate on Progesterone Elevation on the Day of Triggering
Completed NCT03581422 - Natural Cycles With Spontaneous Versus Induced Ovulation in FET
Completed NCT02257359 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers Phase 1
Not yet recruiting NCT06084793 - Music for Anxiety in Embryo Transfers N/A
Completed NCT03201783 - Immediate Versus Delayed FET Following a Stimulated IVF Cycle N/A
Recruiting NCT03518528 - Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer